United Kingdom-based Senzer's pharmaceutical cannabinoid device has received another major design award from the German Design Council, it was reported on Friday.

The award was conferred on the company's unique inhaler for having 'a clear modern design that perfectly combines ergonomics and functionality'. It is the third design success for Senzer's Class IIa Medical Device, which is breath-activated and delivers a precise dose of pharmaceutical cannabinoids, and has been used in a clinical setting for treating side effects linked to cancer treatment. The company received the honour for Excellent Product Design in the category of 'Medical, Rehabilitation and Health Care'

The German Design Council stated that the criteria for the award was for 'projects that truly represent pioneering contributions to the German and international design landscape.'